Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) has announced its participation in the 21st Annual Piper Jaffray Health Care Conference on December 2, 2009. The conference will be held at the New York Palace Hotel in New York, NY. Inspire Pharmaceuticals is scheduled to present at 10:00 am ET that morning. The company’s presentation will be lead by Inspire Pharmaceuticals President and CEO Christy Shaffer Ph.D., and CFO and Treasurer Thomas Staab. Interested parties who are unable to attend the conference may hear the company’s presentation via webcast at http://www.inspirepharm.com/.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Inspire Pharmaceuticals, Inc. (Inspire) biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The Company’s portfolio of products and product candidates include Elestat, Restasis, AzaSite, Prolacria and Denufosol tetrasodium. The advanced compounds in its clinical pipeline are Prolacria for dry eye and denufosol tetrasodium for cystic fibrosis, which are both in Phase III development and AzaSite for blepharitis, which is beginning Phase II development.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
